Resumo
Definição
História e exame físico
Fatores de risco
- adolescência ou adultos jovens
- predisposição genética
- pele oleosa/produção de sebo aumentada
- uso de determinados medicamentos
- uso de terapia com hormônio masculinizante
- endocrinopatias
- fatores alimentares
- sexo feminino
- obesidade/resistência insulínica
- exposição a hidrocarbonetos aromáticos halogenados
Investigações diagnósticas
Algoritmo de tratamento
Colaboradores
Autores
Robert P. Dellavalle, MD, PhD, MSPH
Professor of Dermatology and Public Health
University of Minnesota Dermatology Department
National Dermatology Program Director
US Department of Veterans Affairs
Minneapolis
MN
Declarações
RPD has received editorial stipends (Journal of Medical Internet Research Dermatology (JMIR Dermatology)), royalties (UpToDate), and expenses reimbursement (Cochrane). RPD is an editor-in-chief of JMIR Dermatology, a joint coordinating editor for Cochrane Skin, a dermatology section editor for UpToDate, a social media editor for JAAD, and a coordinating editor representative on the Cochrane Council. He is a Cochrane Council Co-Chair, and serves as the National Dermatology Program Director for the US Department of Veteran Affairs.
Torunn E. Sivesind, MD
Dermatology Resident Physician
University of Colorado Anschutz School of Medicine
Aurora
CO
Declarações
TES previously received fellowship funding from Pfizer and the National Institute of Health; TES previously served as an editorial board member-at-large for the Journal of Medical Internet Research Dermatology.
Agradecimentos
Professor Dellavalle and Dr Sivesind would like to gratefully acknowledge Dr Madeline Adelman, Dr Romerio Rodriguez, Dr Sarah Shangraw, Dr Mark Naftanel, Dr Yolanda Rosi Helfrich, and Dr Amanda Howland, previous contributors to this topic. The authors would like to thank Dr John Barbieri for his review of the topic. JB has received consulting fees from Dexcel Pharma.
Declarações
SS, MN, YRH, and AH declare that they have no competing interests. MA has received fellowship funding from the Pfizer Global Medical Grant, RR receives fellowship funding from the National Institute of Health.
Revisores
Gina Taylor, MD
Resident
Department of Dermatology
SUNY Downstate Medical Center
New York
NY
Declarações
GT declares that she has no competing interests.
Gillian Murphy, MD, FRCPI, FRCP, Edin
Consultant Dermatologist
Dermatology
Beaumont Hospital
Dublin
Ireland
Declarações
Not disclosed.
O uso deste conteúdo está sujeito ao nosso aviso legal